Rituximab Inhibits the In Vivo Primary and Secondary Antibody Response to a Neoantigen, Bacteriophage phiX174

This publication has 40 references indexed in Scilit:

• Hapten-Induced Primary and Memory Humoral Responses Are Inhibited by the Infusion of Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab)
  Clinical Immunology, 2001
• Sensitization following Thymoglobulin and Atgam rejection therapy as determined with a rapid enzyme-linked immunosorbent assay
  Transplant Immunology, 1999
• The OKT3 antibody response study: a multicentre study of human anti-mouse antibody (HAMA) production following OKT3 use in solid organ tranplantation
  Transplant Immunology, 1995
• Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
  Arthritis & Rheumatism, 1993
• Immunologic mechanisms of transplant rejection
  Current Opinion in Nephrology and Hypertension, 1992
• The Use of Vaccines in Renal Failure
  Clinical Pharmacokinetics, 1992
• Comparison of Antimouse and Antihorse Antibody Production during the Treatment of Allograft Rejection with OKT3 or Antithymocyte Globulin
  Nephron, 1987
• Persistence of antibodies to pneumococcal vaccine in patients with chronic renal failure
  Kidney International, 1985
• Defective humoral immunity in pediatric acquired immune deficiency syndrome
  The Journal of Pediatrics, 1985
• Immunologic responses to bacteriophage ϕX 174 in immunodeficiency diseases
  Journal of Clinical Investigation, 1971